Wyss Center Neurotech Challenge: Can You Connect the Human Brain with Digital World?

The Wyss Center, a not-for-profit neurotechnology organization based in Geneva, Switzerland, has launched a global neurotech innovation challenge to connect the human brain with the digital world. The Challenge seeks the most disruptive new technologies for brain stimulation and neural signal recording. The goal is to develop technology with a clinical application that could help paralyzed people move, overcome depression or memory loss, restore vision or address other nervous system disorders.

Open to anyone, from anywhere in the world, the award will provide access to the expertise and technical facilities at the Wyss Center as well as funding to translate the successful idea from research concept into a clinical application.

Accommodation and salary for the project leader in the beautiful Lake Geneva region of Switzerland will be included in the award for a minimum of a year in addition to ongoing funding for the project.

The deadline for entries to the Wyss Center Neurotech Challenge is the 1st February 2017.

Proposals may be sent out for independent external review. A short list will be announced on February 14 and the winner will be announced in April 2017.

For further information, please visit:
http://www.wysscenter.ch/en/neurotech-challenge

About the Wyss Center for Bio and Neuroengineering
The Wyss Center provides the expertise, facilities and resources to accelerate the development of creative neuroscience research into clinical solutions for human benefit.

Based at Campus Biotech in Geneva Switzerland, the Wyss Center offers competitively awarded project funding for innovative neurotechnology research projects that have the potential to make substantial impact.

The Center provides access to advanced neuroscience and engineering facilities, as well as the integrated clinical, regulatory and business resources required to guide high risk, high return projects on their the complex journey from research to product.

The Wyss Center's unique interdisciplinary team of specialists, including research scientists, engineers, regulatory experts, business development specialists and clinicians, help to develop the products that will prevent, diagnose or treat nervous system disorders, or will lead to useful technology with the potential to improve lives.

The Center will support highly innovative neurotechnology projects from anywhere in the world as long as they fit the core mission to accelerate the development of neurotechnology for human benefit and make full use of the Center's capabilities and resources.

Most Popular Now

Gait Assessed with Body-Worn Sensors may…

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the...

Applications for the G4A Global Accelera…

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and...

Siemens Healthineers Fully on Track to M…

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR...

How to Build GDPR and HIPAA Compliant He…

The adoption of cloud and mobile technologies in healthcare is disrupting the services delivery models, and responsibilities and risks for involved actors. By their very nature, eHealth applications collect and...

Computers Equal Radiologists in Assessin…

Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led...

The Big Ethical Questions for Artificial…

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential...

Consultation: Transformation Health and …

The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care...

Novartis Launches FocalView App, Providi…

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data...

International Masters's in Medical Infor…

The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI)in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

Data in the EU: Commission Steps Up Effo…

The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal...

Philips Expands its Sleep & Respirat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has...

A New Way to Watch Brain Activity in Act…

It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology...